Search
Lumasiran
go.drugbank.com/drugs/DB15935ApprovedInvestigational[L23554] This condition, caused by a deficiency in the enzyme alanine-glyoxylate aminotransferase, leads to an accumulation of oxalate, causing calcium crystal formation. … Lumasiran is a small interfering RNA used in the treatment of primary hyperoxaluria type 1 (PH1).
Categories: Alimentary Tract and Metabolism, Nucleic Acids, Nucleotides, and Nucleosidesp-tert-Butylphenol-formaldehyde resin (low molecular weight)
go.drugbank.com/drugs/DB14190Approvedp-tert-Butylphenol-formaldehyde resin is a widely used adhesive chemical used in a wide variety of commercially available products and a known dermatological sensitizer and allergen [A34290,A34291].
Sodium molybdate
go.drugbank.com/drugs/DB14496ApprovedMixtures: Multi Cal Mag Liquid, Tracel Injektionslösung in einer FertigspritzeVarespladib methyl
go.drugbank.com/drugs/DB05737InvestigationalStudies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.
Etofamide
go.drugbank.com/drugs/DB13258ApprovedEtofamide is used as an antiamoebic agent. Etofamide, under the brand name Kitnos, was marketed in Brazil by Pfizer but has been discontinued [L5617].
Categories: Antiparasitic Products, Insecticides and RepellentsDegenerative Joint Disease
go.drugbank.com/conditions/DBCOND0039319Drugs: MethylprednisoloneSynonyms: Osteoarthritis and allied disordersDental Caries Extending Into Dentine
go.drugbank.com/conditions/DBCOND0061100Synonyms: Dental caries confined to enamel and dentineMephentermine
go.drugbank.com/drugs/DB01365ApprovedWithdrawnA sympathomimetic agent with mainly indirect effects on adrenergic receptors. It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia.
Categories: Adrenergic and Dopaminergic AgentsProducts: Wyamine Sulfate Injection Liq 30mg/mlAlveolitis, Extrinsic Allergic
go.drugbank.com/conditions/DBCOND0115831Synonyms: Unspecified allergic alveolitis and pneumonitisLoncastuximab tesirine
go.drugbank.com/drugs/DB16222ApprovedInvestigational[L45206] This therapy was developed by ADC Therapeutics and its accelerated approval for relapsed or refractory B-cell lymphoma is based on promising results from the LOTIS-2 clinical trial. … [A234439] Prognosis is poor and more effective therapies are needed to treat relapsed/refractory cases and improve survival.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating Agents